Companies / Century Therapeutics, Inc. / Activity
Activity — Century Therapeutics, Inc.
18 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Cowan Chad Executive | Grant | Common Stock | $0 | +135K +12.94% | 1,178,476 0.65% of shares | low |
| Feb 2, 2026 | Pfeiffenberger Brent CEO | Grant | Common Stock | $0 | +475K +14.29% | 3,797,990 2.10% of shares | low |
| Feb 2, 2026 | Russotti Gregory Executive | Grant | Common Stock | $0 | +135K +34.53% | 525,982 0.29% of shares | low |
| Feb 2, 2026 | Carr Douglas Executive | Grant | Common Stock | $0 | +110K +27.17% | 514,874 0.28% of shares | low |
| Feb 3, 2026 | Carr Douglas Executive | Sell | Common Stock | $589 | -323 -0.06% | 514,551 0.28% of shares | low |
| Mar 9, 2026 | Carr Douglas Executive | Sell | Common Stock | $626 | -247 -0.05% | 514,304 0.28% of shares | low |
| Mar 6, 2026 | Pfeiffenberger Brent CEO | Other | Common Stock | $1.2K | -463 -0.01% | 3,766,355 2.08% of shares | low |
| Mar 9, 2026 | Russotti Gregory Executive | Sell | Common Stock | $1.2K | -479 -0.09% | 525,503 0.29% of shares | low |
| Jan 2, 2026 | Cowan Chad Executive | Other | Common Stock | $1.6K | -2K -0.15% | 1,043,476 0.58% of shares | low |
| Mar 11, 2026 | Cowan Chad Executive | Other | Common Stock | $3.9K | -1K -0.12% | 1,177,045 0.65% of shares | low |
| Mar 12, 2026 | Carr Douglas Executive | Sell | Common Stock | $18.0K | -7K -1.37% | 507,261 0.28% of shares | low |
| Mar 12, 2026 | Russotti Gregory Executive | Sell | Common Stock | $25.7K | -10K -1.92% | 515,427 0.28% of shares | low |
| Feb 13, 2026 | Pfeiffenberger Brent CEO | Other | Common Stock | $54.6K | -31K -0.82% | 3,766,818 2.08% of shares | low |
| Mar 11, 2026 | Pfeiffenberger Brent CEO | Other | Common Stock | $151.2K | -55K -1.47% | 3,710,958 2.05% of shares | low |
| Feb 2, 2026 | Cowan Chad Executive | Grant | Stock Option (right to buy) | — | +265K | 265,000 0.15% of shares | low |
| Feb 2, 2026 | Pfeiffenberger Brent CEO | Grant | Stock Option (right to buy) | — | +945K | 945,000 0.52% of shares | low |
| Feb 2, 2026 | Russotti Gregory Executive | Grant | Stock Option (right to buy) | — | +265K | 265,000 0.15% of shares | low |
| Feb 2, 2026 | Carr Douglas Executive | Grant | Stock Option (right to buy) | — | +225K | 225,000 0.12% of shares | low |